DexCom (NASDAQ:DXCM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Monday. Several other brokerages also recently issued reports on DXCM. Barclays upped their target price on shares of DexCom from $115.00 to $138.00 and gave the stock an “equal […]